A DAY WITH THE JUDGES
National Conference on Professional Ethics, Marijuana and Opioid Crisis, presented jointly by ACLM and WILM
Need Information, Please Contact:
Program Chair: S. Sandy Sanbar, MD, PhD, JD
Phone: (405) 229-7295
Email: sandysanbar@gmail.com
​
​
A DAY WITH THE JUDGES
National Mid-Year Conference Co-Sponsored by the ACLM and WILM
Professional Ethics, Marijuana (Cannabis) and Opioid Crisis
Up to 12 Hours CME; 7 Hours CLE
Friday, October 18, 2019, Oklahoma City, Oklahoma
Course Fee $275.00
10% Discount ($247.50) for Early Bird Seminar Registration
​
​
Opioid Materials and Drug Courts
​
TO REGISTER: Please go to HOME page, and click on the button REGISTER NOW.
In case of problems, email sandysanbar@gmail.com your name, address and telephone number. Will be register and bill.
Opioids - General Topics
Drug Courts Materials
Preventing Opioid Overdose and Death
Medications for Opioid Use Disorder Save Lives (2019)
National Academies of Sciences, Engineering, and Medicine 2019. Washington, DC: The National Academies Press.
https://doi.org/10.17226/25310.
Summary of Conclusions
-
Opioid use disorder is a treatable chronic brain disease.
-
U.S. Food and Drug Administration (FDA)-approved medications to treat opioid use disorder are effective and save lives.
-
Long-term retention on medications to treat opioid use disorder is associated wit improved outcomes.
-
A lack of availability of behavioral interventions is not a sufficient justification to
-
withhold medications to treat opioid use disorder.
-
Most people who could benefit from medication-based treatment for opioid use disorder do not receive it, and access is inequitable across subgroups of the population.
-
Medication-based treatment is effective across all treatment settings studied to date. Withholding or failing to have available all classes of FDA-approved medication for the treatment of opioid use disorder in any care or criminal justice setting is denying appropriate medical treatment.
-
Confronting the major barriers to the use of medications to treat opioid use disorder is critical to addressing the opioid crisis.
Oklahoma Medical Board
Documents on
Controlled Substances